FGF21 and type 1 diabetes mellitus: In STZ- induced type 1 diabetes in this study, circulating FGF21 reduced from 1 month to the experimental termination at 4 months after diabetes onset (Fig.1C), which was consistent with a previous report that serum FGF21 levels were significantly lower in type 1 diabetic patients than that of control subjects 37.